DK2114452T3 - Forbedrede medicinsammensætninger omfattende buprenorfin og nalmefen - Google Patents

Forbedrede medicinsammensætninger omfattende buprenorfin og nalmefen

Info

Publication number
DK2114452T3
DK2114452T3 DK08709413.2T DK08709413T DK2114452T3 DK 2114452 T3 DK2114452 T3 DK 2114452T3 DK 08709413 T DK08709413 T DK 08709413T DK 2114452 T3 DK2114452 T3 DK 2114452T3
Authority
DK
Denmark
Prior art keywords
nalmefene
compositions including
drug compositions
improved drug
including buprenorphine
Prior art date
Application number
DK08709413.2T
Other languages
English (en)
Inventor
Christopher Bourne Chapleo
Neil Hyde
Original Assignee
Rb Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rb Pharmaceuticals Ltd filed Critical Rb Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK2114452T3 publication Critical patent/DK2114452T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK08709413.2T 2007-03-01 2008-02-15 Forbedrede medicinsammensætninger omfattende buprenorfin og nalmefen DK2114452T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0703933A GB2447013A (en) 2007-03-01 2007-03-01 Analgesic composition containing buprenorphone and nalmefene
PCT/GB2008/000522 WO2008104736A1 (en) 2007-03-01 2008-02-15 Improved medicinal compositions comprising buprenorphine and nalmefene

Publications (1)

Publication Number Publication Date
DK2114452T3 true DK2114452T3 (da) 2014-06-30

Family

ID=37965707

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08709413.2T DK2114452T3 (da) 2007-03-01 2008-02-15 Forbedrede medicinsammensætninger omfattende buprenorfin og nalmefen

Country Status (22)

Country Link
US (1) US8497280B2 (da)
EP (1) EP2114452B1 (da)
JP (1) JP5577102B2 (da)
KR (1) KR101437461B1 (da)
CN (1) CN101622012B (da)
AR (1) AR065582A1 (da)
AU (1) AU2008220572B2 (da)
BR (1) BRPI0807903A2 (da)
CA (1) CA2678568C (da)
CL (1) CL2008000607A1 (da)
DK (1) DK2114452T3 (da)
ES (1) ES2476865T3 (da)
GB (1) GB2447013A (da)
HK (1) HK1139868A1 (da)
HR (1) HRP20140591T1 (da)
MX (1) MX2009009134A (da)
PE (2) PE20090625A1 (da)
PL (1) PL2114452T3 (da)
PT (1) PT2114452E (da)
TW (1) TWI468163B (da)
WO (1) WO2008104736A1 (da)
ZA (1) ZA200905692B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
ME02622B (me) * 2009-05-25 2017-06-20 H Lundbeck As Pripremanje nalmefen hidrohlorida od naltreksona
EA201491875A1 (ru) 2012-04-17 2015-04-30 Пурдью Фарма Л.П. Системы и способы лечения индуцированного опиоидами побочного фармакодинамического ответа
CN103637983B (zh) * 2013-12-16 2017-08-04 科贝源(北京)生物医药科技有限公司 一种含有盐酸纳美芬的药物组合物及其制备方法
US9849124B2 (en) 2014-10-17 2017-12-26 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
CN104922061B (zh) * 2015-05-26 2017-09-22 成都天台山制药有限公司 盐酸纳美芬注射液药物组合物和制法
CN112272554A (zh) * 2018-02-22 2021-01-26 艾维奥尔股份有限公司 经粘膜的膜组合物及其制备和使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728294D0 (en) * 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5272149A (en) * 1992-05-05 1993-12-21 Stalling Reginald W Symptom controlled receptor substitution for addiction withdrawl
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
EP1041988A4 (en) * 1997-12-22 2002-03-13 Euro Celtique Sa METHOD FOR PREVENTING ABUSE OF OPIOID DOSES FORMS
AR031682A1 (es) * 1999-11-19 2003-10-01 Reckitt Benckiser Helthcare Uk Composiciones farmaceuticas
US20050191340A1 (en) * 2002-08-09 2005-09-01 Gruenenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine
US20100137239A1 (en) * 2006-04-24 2010-06-03 Gloucester Pharmaceuticals Gemcitabine combination therapy
WO2007146730A2 (en) * 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Deacetylase inhibitor therapy
WO2008088331A1 (en) * 2007-01-19 2008-07-24 Gloucester Pharmaceuticals Methods for increasing levels of human fetal hemoglobin

Also Published As

Publication number Publication date
US20100152222A1 (en) 2010-06-17
EP2114452B1 (en) 2014-04-09
GB0703933D0 (en) 2007-04-11
PE20120956A1 (es) 2012-08-01
EP2114452A1 (en) 2009-11-11
US8497280B2 (en) 2013-07-30
GB2447013A (en) 2008-09-03
BRPI0807903A2 (pt) 2014-06-17
AU2008220572B2 (en) 2014-03-27
PT2114452E (pt) 2014-07-15
TW200900067A (en) 2009-01-01
ZA200905692B (en) 2010-10-27
KR101437461B1 (ko) 2014-09-05
PL2114452T3 (pl) 2014-09-30
CA2678568A1 (en) 2008-09-04
JP2010520184A (ja) 2010-06-10
PE20090625A1 (es) 2009-06-04
KR20090115862A (ko) 2009-11-09
ES2476865T3 (es) 2014-07-15
CL2008000607A1 (es) 2008-10-03
MX2009009134A (es) 2009-09-03
AR065582A1 (es) 2009-06-17
CN101622012A (zh) 2010-01-06
CN101622012B (zh) 2012-05-30
TWI468163B (zh) 2015-01-11
HK1139868A1 (en) 2010-09-30
AU2008220572A1 (en) 2008-09-04
CA2678568C (en) 2015-06-16
WO2008104736A1 (en) 2008-09-04
HRP20140591T1 (hr) 2014-09-12
JP5577102B2 (ja) 2014-08-20

Similar Documents

Publication Publication Date Title
DK2125019T3 (da) Forbedrede medicinsammensætninger omfattende buprenorfin og naltrexon
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
BRPI0924135A2 (pt) composição farmacêutica sólida compreendendo anlodipino e losartan
DK2285411T3 (da) Nikotintabletsammensætninger
ZA201004305B (en) Quinoline derivatives and their use as fungicides
BRPI0807905A2 (pt) Composições medicinais aperfeiçoadas compreendendo buprenorfina e naloxona.
BRPI1006186A2 (pt) composições farmaceuticas de liberação imediata compreedendo oxicodona e naloxona
EP2154966A4 (en) BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
HK1139153A1 (en) Quinolone compound and pharmaceutical composition
IL232459A0 (en) Quinolone compound and pharmaceutical preparation
DK2114452T3 (da) Forbedrede medicinsammensætninger omfattende buprenorfin og nalmefen
EP2391368A4 (en) DETERGENT FOR DRUG ABUSE, PROCEDURE AND COMPOSITIONS
DK2231603T3 (da) Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf
TH0801002797A (th) สารประกอบควินอโลน และองค์ประกอบทางเภสัชกรรม
TH0901005464A (th) สารประกอบควิโนโลน และองค์ประกอบทางเภสัชกรรม